Public Notifications

Search

Search Results

Search Again
Pharmacist Registrant 60 (Aug 25, 2025)

The Inquiry Committee has removed all limits placed on the pharmacist registrant’s registration. The pharmacist registrant’s name has been withheld pursuant to s. 39.3(4) of the Health Professions Act.

May 26, 2025

The Inquiry Committee, pursuant to s. 32.2(4)(b)(i) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily limit their scope of practice as a pharmacist effective May 26, 2025. The pharmacist registrant will be limited to only practice pharmacy in the presence of another registrant (pharmacy technician or pharmacist). The Agreement remains in effect for 3 months starting from the date the pharmacist registrant returns to work. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to s. 39.3(4)(a) of the Health Professions Act.

Hanna, Samy Samir Farag (Jul 18, 2025)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Samy Samir Farag Hanna (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183 (“HPA”).

The Inquiry Committee and the Registrant agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the HPA.

  1. Effective date: July 18, 2025
  1. Name of registrant: Samy Samir Farag Hanna
  1. Location of Practice: Prince George, BC
  1. Admissions and Acknowledgments:
    The Inquiry Committee determined, and the Registrant has acknowledged that while practicing as a pharmacist and pharmacy manager, he:
  1. Provided emergency supplies of methadone to a patient who had missed six (6) consecutive doses, which were determined to be inappropriate and did not meet the requirements outlined in Professional Practice Policy-31 – Emergency Supply for Continuity of Care.
  2. Failed to notify the original prescriber of any missed methadone doses, or the cancellation of the patient’s methadone prescription after four (4) consecutive missed doses, contrary to the principles of Professional Practice Policy-66 – Policy Guide for Methadone Maintenance Treatment.
  3. Did not ensure the correct practitioner’s credentials were transmitted to PharmaNet when processing prescription transactions for the patient.
  4. Did not perform an adequate final check prior to dispensing methadone prescriptions for the patient.
  5. Did not maintain adequate policies and procedures related to dispensing Opioid Agonist Treatment.

This incident was the fourth time that the Registrant’s practice has been the subject of an Inquiry Committee matter related to the inappropriate dispensing of OAT prescriptions. The Registrant had previously signed Consent Agreements, where he provided undertakings to remediate his practice to prevent recurrences of a similar nature.

  1. Disposition:
    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to terms that included (but are not limited to) the following:
  1. To be limited from acting in the capacity of a pharmacy manager, or preceptor for pharmacy students for a period of 180 days from July 28, 2025 to January 24, 2026; 
  2. To pay a fine of $500;
  3. To, at his own cost, successfully complete and pass the “BCPhA Opioid Agonist Treatment Compliance and Management Program for Pharmacy” within 180 days of signing the Consent Agreement, and submit a certificate of completion to the College;
  4. To not dispense any narcotic or controlled drug substance(s) intended for Opioid Agonist Treatment, until he has successfully completed the “BCPhA Opioid Agonist Treatment Compliance and Management Program for Pharmacy” and received confirmation from the College that this limit on his practice has been removed;
  5. To receive a letter of reprimand, which will placed in the College register for a period of two (2) years;
  6. To thoroughly review and read legislation, standards, and policies relevant to the conduct to which this matter relates; and
  7. To thoroughly review and complete the Code of Ethics: Educational Tutorial.
  1. Rationale:
    The Inquiry Committee determined that the Registrant’s actions did not appear to have been carried out with ill-intent and appeared to be out of concern for the patient’s well-being in a specific circumstance. However, his actions lacked objective consideration for patient safety given the clinical context and demonstrated a deficiency in his professional competence and judgment. The Inquiry Committee also considered that the Registrant’s conduct showed a disregard for his responsibilities as a pharmacist and pharmacy manager, especially given his previous undertakings to address similar practice concerns related to OAT dispensing.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 
Pharmacist Registrant 28 (Jul 17, 2025)

The Inquiry Committee has approved to change the pharmacist’s registration back to Active status after they had previously been suspended for an indefinite period on December 19, 2023. Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To remain in full compliance with their medical monitoring agreement for a minimum of five (5) years following their return to active employment as a pharmacist, unless otherwise directed;
     
  2. To ensure they notify the monitoring organization of any pharmacist employment;
     
  3. To comply with any and all treatment plans as recommended by their medical providers;
     
  4. To comply with any and all return to work plans as advised by their medical providers and/or employers;
     
  5. To voluntarily stop working as a pharmacist and self-report to the College in the event that their medical condition may hinder their performance and/or fitness to practice as a pharmacist;
     
  6. To authorize and direct any and all caregivers, treating physicians and/or institution(s) to furnish the College with a written report and any and all information that relates to their health, including and diagnosis, prognosis, status of recovery and/or treatment plan pertaining to their health condition and recovery, when and if necessary for the College to obtain such information; and
     
  7. To authorize the College to provide their treating physician(s) and any practitioner involved in their care with any information and documentation necessary for an independent medical assessment as well as monitoring and/or follow-up therapy, as necessary.

The Inquiry Committee considers this Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

December 19, 2023


The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective December 19, 2023. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 61 (Jul 9, 2025)

The Inquiry Committee, pursuant to section 32.3(3)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend their registration as a pharmacist effective July 9, 2025. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Chohan, Karandeep Singh (May 27, 2025)

Description of Action:

A panel of the Inquiry Committee (the “Panel”) of the College of Pharmacists of British Columbia (the “College”) has ordered that, effective May 27, 2025, the registration of pharmacist Karandeep Singh Chohan (the “Registrant”) is suspended pending completion of the investigation and any resulting disciplinary hearing.

While his registration is suspended, the Registrant must not practice pharmacy in British Columbia, must not act as a pharmacy manager, and must not hold himself out as being a registrant of the College.

This interim suspension order is made pursuant to the authority for taking extraordinary action under section 35 of the Health Professions Act. Suspension under this authority requires the Inquiry Committee to be satisfied that the evidence shows there is a real risk of harm to patients, pharmacy professionals or other members of the public if the order is not made. However, it is important to note that the Inquiry Committee has not made any findings of fact or any findings as to whether any allegations regarding the Registrant are or are not proven.

Reasons for Action:

The Registrant was the pharmacy manager of Fraser Outreach Pharmacy (the “Pharmacy”), located at 4127 Fraser Street in the city of Vancouver.

The College received concerns from a healthcare provider regarding the provision of Opioid Agonist Treatment (“OAT”) services by the Pharmacy’s staff. In May 2024, College inspectors performed an onsite inspection of the Pharmacy. In August 2024, College inspectors performed a follow-up onsite inspection of the Pharmacy. In both instances, College inspectors identified what appeared to be multiple breaches of the College’s bylaws and standards under the Health Professions Act and the Pharmacy Operations and Drug Scheduling Act.

Based on the information before it, the Panel concluded that the Registrant’s continued practice of pharmacy and management of the Pharmacy poses a real risk to patients and other members of the public. Under the Registrant’s management of the Pharmacy, allegations have been identified regarding the following matters:

  • Inadequate narcotic inventory control and management
  • Inadequate prescription final check requirements
  • Inaccurate PharmaNet record keeping
  • Inadequate patient consultations
  • Non-compliance with OAT dispensing standards
  • Non-compliance with OAT delivery standards
  • Inadequate supervision of non-registrant staff
  • Breaches of Standards 6, 7, and 9 of the Code of Ethics relating to Benefiting Society, Personal and Professional Integrity, and Ethical Business Practices respectively

The Panel considered that the Registrant had been previously investigated for similar concerns on five previous occasions between 2016 and 2023. The Panel noted that, as a result of those previous investigations, the Registrant had declared his remediation of the concerns identified at that time and his understanding of legislated requirements and had given undertakings to abide by those requirements in future.

The Panel considered what interim measures would be sufficient and proportionate in this case. Given the Registrant’s previous investigations and his history of making undertakings and declarations involving the same or similar conduct, the Panel was concerned that the Registrant may not abide by limits and conditions placed on his registration. Therefore, having weighed the available options and the circumstances of the case, and having considered the impact on the Registrant, the Panel concluded that protection of the public can only be achieved through an interim suspension of the Registrant’s registration. 

Fraser Outreach Pharmacy (May 27, 2025)

Description of Action:

A panel of the Inquiry Committee (the “Panel”) of the College of Pharmacists of British Columbia (the “College”) has ordered that, effective May 27, 2025, the pharmacy licence of Fraser Outreach Pharmacy (the “Pharmacy”) located at 4127 Fraser Street in the city of Vancouver is suspended pending completion of the investigation and any resulting disciplinary hearing.

This interim suspension order is made pursuant to the authority for taking extraordinary action under section 35 of the Health Professions Act and section 20 of the Pharmacy Operations and Drug Scheduling Act. Suspension under this authority requires the Inquiry Committee to be satisfied that the evidence shows there is a real risk of harm to patients, pharmacy professionals or other members of the public if the order is not made. However, it is important to note that the Inquiry Committee has not made any findings of fact or any findings as to whether any allegations regarding the Pharmacy are or are not proven.

Reasons for Action:

The Pharmacy’s manager and sole indirect owner was pharmacist Karandeep Singh Chohan (the “Registrant”). The College has issued a separate public notification regarding the Registrant’s registration.

The College received concerns from a healthcare provider regarding the provision of Opioid Agonist Treatment (“OAT”) services by the Pharmacy’s staff. In May 2024, College inspectors performed an onsite inspection of the Pharmacy. In August 2024, College inspectors performed a follow-up onsite inspection of the Pharmacy. In both instances, College inspectors identified what appeared to be multiple breaches of the College’s bylaws and standards under the Health Professions Act and the Pharmacy Operations and Drug Scheduling Act.

Based on the information before it, the Panel concluded that the Pharmacy’s continued operation poses significant risks to individual patients and the public. Under the Registrant’s management of the Pharmacy, allegations have been identified regarding the following matters:

  • Inadequate narcotic inventory control and management
  • Inadequate prescription final check requirements
  • Inaccurate PharmaNet record keeping
  • Inadequate patient consultations
  • Non-compliance with OAT dispensing standards
  • Non-compliance with OAT delivery standards
  • Inadequate supervision of non-registrant staff
  • Breaches of Standards 6, 7, and 9 of the Code of Ethics relating to Benefiting Society, Personal and Professional Integrity, and Ethical Business Practices respectively

The Panel considered what interim measures would be sufficient and proportionate in this case. Due to the scope and nature of the alleged deficiencies in the Pharmacy’s operations, the Panel was not satisfied that interim limits and conditions would adequately protect the public. Therefore, having weighed the available options and circumstances of the case, and having considered the impact on the Pharmacy’s operations, the Panel concluded that protection of the public can only be achieved through an interim suspension of the Pharmacy’s license. 

Note:  **Effective April 14, 2025, the Pharmacy’s pharmacy license has been cancelled as a result of a change in direct owner due to the sale of the Pharmacy. 

Pal, Charanjt (May 12, 2025)

Description of Action:

A panel of the Inquiry Committee (the “Panel”) of the College of Pharmacists of British Columbia (the “College”) has ordered that, effective May 12, 2025, there will be limits and conditions imposed on the practice of pharmacist Charanjit Pal (the “Registrant”), pending completion of the investigation and any resulting disciplinary hearing.

The limits and conditions include:

  1. That the Registrant does not work at either Fraser Neighbourhood Pharmacy or Fraser Outreach Pharmacy in any form or capacity;
  1. That the Registrant does not work with registrant Karandeep Singh Chohan in any form or capacity;
  1. That the Registrant notify the College in writing of every pharmacy at which he works;
  1. That the Registrant does not provide Opioid Agonist Treatment (“OAT”) services in any form or capacity;
  1. That the Registrant does not provide any services related to narcotics in any form or capacity;
  1. That the Registrant does not provide any services related to “safe supply” in any form or capacity;
  1. That the Registrant does not provide any pharmacy delivery services in any form or capacity;
  1. That the Registrant does not act as a pharmacy manager, preceptor, supervisor or pharmacy owner at any pharmacy; and
  1. That the Registrant does not delegate any aspect of his practice to any other person, including to any pharmacy assistants.

This interim order is made pursuant to the authority for taking extraordinary action under section 35 of the Health Professions Act. Interim action under this authority requires the Inquiry Committee to be satisfied that the evidence shows there is a real risk of harm to patients, pharmacy professionals or other members of the public if the order is not made. However, it is important to note that the Inquiry Committee has not made any findings of fact or any findings as to whether any allegations regarding the Registrant are or are not proven.

Reasons for Action:

The Registrant is the pharmacy manager of Fraser Neighbourhood Pharmacy (the “Pharmacy”), located at 3373 Fraser Street in the city of Vancouver.

The College received concerns from healthcare providers regarding the provision of OAT services by the Pharmacy’s staff. In April 2024, College inspectors performed an onsite inspection of the Pharmacy and identified what appeared to be multiple breaches of the College’s bylaws and standards under the Health Professions Act and the Pharmacy Operations and Drug Scheduling Act.

Based on the information before it, the Panel concluded that there is a real risk to patients or other members of the public if an interim order is not made. Under the Registrant’s management of the Pharmacy, allegations have been identified regarding the following matters:

  • Inadequate narcotic inventory control and management
  • Inadequate prescription final check requirements
  • Inaccurate PharmaNet record keeping
  • Inadequate patient consultations
  • Non-compliance with OAT dispensing standards
  • Non-compliance with OAT delivery standards
  • Inadequate supervision of non-registrant staff
  • Breaches of Standards 6, 7, and 9 of the Code of Ethics relating to Benefiting Society, Personal and Professional Integrity, and Ethical Business Practices respectively

The Panel considered that the Registrant had been previously investigated for similar concerns at a different pharmacy in 2021. The Panel noted that, as a result of that previous investigation, the Registrant had signed a declaration acknowledging his understanding of the legislated requirements.

The Panel considered what interim measures would be sufficient and proportionate in this case. After having weighed the different options and circumstances of the case, and after considered the impact on the Registrant, the Panel concluded that limits and conditions on the Registrant’s practice were necessary to protect the public.

Malaviya, Mitesh Vaghajibhai (May 2, 2025)
  1. Nature of Action: 

    The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Mitesh Vaghajibhai Malaviya (the “Registrant”), pursuant to section 33(4) of the Health Professions Act RSBC 1996 c 183 (the “HPA”).

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the HPA.

  2. Effective date: May 2, 2025 

  3. Name of registrant: Mitesh Vaghajibhai Malaviya

  4. Location of Practice: Abbotsford, BC

  5. Admissions and Acknowledgments:

    The Registrant has admitted and/or acknowledged that while practicing as a pharmacist and acting as pharmacy manager at a pharmacy he:

    1. Fraudulently refunded approximately $18,323.23 to three of his own personal credit cards and in cash to himself; and

    2. Subsequently repaid to his employer the amount he defrauded.

    Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein he consented to terms that included (but are not limited to) the following:

    1. To be suspended as a registrant of the College for a period of sixty (60) days from May 5, 2025 to July 3, 2025;

    2. To not act in any of the following roles for a period of three (3) years following the completion of his suspension:

      • Manager of a pharmacy
      • Director or officer of a pharmacy
      • Preceptor or supervisor of pharmacy students and/or international pharmacy graduates

       

    3. To pay a fine in the amount of $1,500.00;

    4. To, at his own cost, complete and successfully pass an ethics course for healthcare professionals within 180 days of signing the Consent Agreement;

    5. To have a letter of reprimand placed on the College register for a period of two (2) years;

    6. To thoroughly review and read legislation, standards, and policies relevant to the conduct to which this matter relates; and

    7. To thoroughly review and complete the Code of Ethics: Educational Tutorial.

  6. Rationale:

    The Inquiry Committee considered the Registrant’s actions were serious and amounted to professional misconduct. It further determined that the Consent Agreement ought to include terms that are punitive in nature owing to the Registrant’s dishonest conduct.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to remediate the Registrant’s conduct, deter his behaviour, protect the public, as well as send a clear message of deterrence to the profession. 

Latchman, Mamteshwari Ravnita (Mar 24, 2025)

Description of Action:

A panel of the Inquiry Committee (the “Panel”) of the College of Pharmacists of British Columbia (the “College”) has ordered that, effective March 24, 2025, there will be limits and conditions imposed on the practice of pharmacist Mamteshwari Ravnita Latchman (the “Registrant”), pending completion of the investigation and any resulting disciplinary hearing.

The limits and conditions include:

  1. That the Registrant does not work at Fraser Outreach Pharmacy or Fraser Neighborhood Pharmacy in any form or capacity;
  1. That the Registrant does not work with registrant Karandeep Singh Chohan or registrant Charanjit Pal in any form or capacity;
  1. That the Registrant notify the College in writing of every pharmacy where she works;
  1. That the Registrant does not provide any Opioid Agonist Treatment (“OAT”) services in any form or capacity;
  1. That the Registrant does not provide any services related to "safe supply" in any form or capacity; and
  1. That the Registrant does not act as pharmacy manager, preceptor, supervisor or owner at any pharmacy in any form or capacity.

This interim order is made pursuant to the authority for taking extraordinary action under section 35 of the Health Professions Act. Interim action under this authority requires the Inquiry Committee to be satisfied that the evidence shows there is a real risk of harm to patients, pharmacy professionals or other members of the public if the order is not made. However, it is important to note that the Inquiry Committee has not made any findings of fact or any findings as to whether any allegations regarding the Registrant are or are not proven.

Reasons for Action:

The Registrant was employed as a staff pharmacist at Fraser Outreach Pharmacy (the “Pharmacy”), located at 4127 Fraser Street in the city of Vancouver.

The College received concerns from a healthcare provider regarding the provision of OAT services by the Pharmacy’s staff. In May 2024, College inspectors performed an onsite inspection of the Pharmacy. In August 2024, College inspectors performed a follow-up onsite inspection of the Pharmacy. In both instances, College inspectors identified what appeared to be multiple breaches of the College’s bylaws and standards under the Health Professions Act and the Pharmacy Operations and Drug Scheduling Act.

Based on the information before it, the Panel concluded that there is a real risk to patients or other members of the public if an interim order is not made. With regards to the Registrant’s practice at the Pharmacy, allegations have been identified regarding the following matters:

  • Inadequate narcotic inventory control and management
  • Inadequate prescription final check requirements
  • Inaccurate PharmaNet record keeping
  • Inadequate patient consultations
  • Non-compliance with OAT dispensing standards
  • Non-compliance with OAT delivery standards
  • Inadequate supervision of non-registrant staff
  • Breaches of Standards 6, 7, and 9 of the Code of Ethics relating to Benefiting Society, Personal and Professional Integrity, and Ethical Business Practices respectively

The Panel considered what interim measures would be sufficient and proportionate in this case. After having weighed the different options and circumstances of the case, and after considered the impact on the Registrant, the Panel concluded that limits and conditions on the Registrant’s practice were necessary to protect the public.

Bui, Jennifer Van (Mar 24, 2025)

Description of Action:

A panel of the Inquiry Committee (the “Panel”) of the College of Pharmacists of British Columbia (the “College”) has ordered that, effective March 24, 2025, there will be limits and conditions imposed on the practice of pharmacist Jennifer Van Bui (the “Registrant”), pending completion of the investigation and any resulting disciplinary hearing.

The limits and conditions include:

  1. That the Registrant does not work at Fraser Outreach Pharmacy or Fraser Neighborhood Pharmacy in any form or capacity;
  2. That the Registrant does not work with registrant Karandeep Singh Chohan or registrant Charanjit Pal in any form or capacity;
  3. That the Registrant notify the College in writing of every pharmacy where she works;
  4. That the Registrant does not provide any Opioid Agonist Treatment (“OAT”) services in any form or capacity;
  5. That the Registrant does not provide any services related to "safe supply" in any form or capacity; and
  6. That the Registrant does not act as pharmacy manager, preceptor, supervisor or owner at any pharmacy in any form or capacity.

This interim order is made pursuant to the authority for taking extraordinary action under section 35 of the Health Professions Act. Interim action under this authority requires the Inquiry Committee to be satisfied that the evidence shows there is a real risk of harm to patients, pharmacy professionals or other members of the public if the order is not made. However, it is important to note that the Inquiry Committee has not made any findings of fact or any findings as to whether any allegations regarding the Registrant are or are not proven.

Reasons for Action:

The Registrant was employed as a staff pharmacist at Fraser Outreach Pharmacy (the “Pharmacy”), located at 4127 Fraser Street in the city of Vancouver.

The College received concerns from a healthcare provider regarding the provision of OAT services by the Pharmacy’s staff. In May 2024, College inspectors performed an onsite inspection of the Pharmacy. In August 2024, College inspectors performed a follow-up onsite inspection of the Pharmacy. In both instances, College inspectors identified what appeared to be multiple breaches of the College’s bylaws and standards under the Health Professions Act and the Pharmacy Operations and Drug Scheduling Act.

Based on the information before it, the Panel concluded that there is a real risk to patients or other members of the public if an interim order is not made. With regards to the Registrant’s practice at the Pharmacy, allegations have been identified regarding the following matters:

  • Inadequate narcotic inventory control and management
  • Inadequate prescription final check requirements
  • Inaccurate PharmaNet record keeping
  • Inadequate patient consultations
  • Non-compliance with OAT dispensing standards
  • Non-compliance with OAT delivery standards
  • Inadequate supervision of non-registrant staff
  • Breaches of Standards 6, 7, and 9 of the Code of Ethics relating to Benefiting Society, Personal and Professional Integrity, and Ethical Business Practices respectively

The Panel considered what interim measures would be sufficient and proportionate in this case. After having weighed the different options and circumstances of the case, and after considered the impact on the Registrant, the Panel concluded that limits and conditions on the Registrant’s practice were necessary to protect the public.

Pages